Experts have developed a new drug to prevent age-related macular degeneration with excellent results in animals. Photo: File
Berkeley, California: Scientists at the University of California have developed a short-molecule drug that could be effective against the leading cause of age-related blindness, called age-related macular degeneration (AMD).
In addition, it may be a useful treatment for diabetic retinopathy (RD) and retinitis pigmentosa (RP). This drug has been named as ‘Stress Resilience Enhancing Drug’ (SRAD). When the drug was tested in several animal models, it significantly prevented vision loss in both hereditary and senile conditions.
Dr. Donald Breen of the UCL School of Medicine and his colleagues found that SRED actually protects the inner tissue by reducing the stress intensity within the retina. ) exists in
It should be noted that AMD is a condition that affects at least 400 million people worldwide and its treatment options are very limited and less effective. This is the reason why experts have been busy treating this condition for a long time.
But still the destination of human trials is far away.
(function(d, s, id){
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) {return;}
js = d.createElement(s); js.id = id;
js.src = “//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.3&appId=770767426360150”;
fjs.parentNode.insertBefore(js, fjs);
}(document, ‘script’, ‘facebook-jssdk’));
(function(d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = “//connect.facebook.net/en_GB/sdk.js#xfbml=1&version=v2.7”;
fjs.parentNode.insertBefore(js, fjs);
}(document, ‘script’, ‘facebook-jssdk’));